Invitris Analysis: $125K Raised
What is Invitris?
Invitris develops synthetic proteins using a universal platform technology, focusing on human therapeutics and industrial applications with high yields and purity.
Employees
6
Founded
2022
Company Stage
Seed
YC Batch
W23
Product Features & Capabilities
- human therapeutics, industrial applications, synthetic proteins, phages, tailocins, endolysins, neoantigens, vaccines, antibodies, toxic proteins (nucleases, proteases), prokaryotic cell-free expression systems, eukaryotic cell-free expression systems, applications in human health, agriculture, anim
How much Invitris raised
1 - $125K
2023Lead Investor: Y Combinator
Who are the founders of Invitris
PG
Patrick Grossman
CEO & Co-Founder
KV
Kilian Vogele
CTO & Co-Founder
Investors
- 10x Founders
- another.vc
- European Innovation Council Fund
- Mergus Ventures
- Phoenix Investment
